Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06171204
Other study ID # BC-07772
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 19, 2022
Est. completion date December 31, 2026

Study information

Verified date December 2023
Source University Hospital, Ghent
Contact Bernard Depypere, MD
Phone 093325730
Email bernard.depypere@ugent.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.


Description:

Stromal Vascular Fraction (SVF) from adipose tissue is increasingly being used in the clinic for a variety of conditions (skin disorders, joint pain, etc.). SVF is a collective term for cells that can be obtained from liposuction fat. These cells can be separated from the fat by mechanical processing of the liposuction fat combined with an additional centrifugation. Despite the fact that enough SVF can be isolated after such a liposuction for multiple treatments (>3), our research group has found a way to safely freeze SVF without significant loss of SVF cells. In this way, a patient would only have to undergo one liposuction and associated anesthesia to be able to obtain multiple SVF treatments.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date December 31, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Legal capacity - Osteochondral lesions - Inflammatory complaints - (Peri)tendinitis or tendinopathies and ligamentous injuries - Impingement complaints - Arthrofibrosis - Anterior knee pain

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Injection of SVF in fat pad of the knee
Knee fat pad injection with SVF at orthopaedics/physical medicine outpatient clinic

Locations

Country Name City State
Belgium UZ GENT Gent Oost-Vlaanderen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the safety of SVF injections after cryo preservation The patient will complete the KOOS questionnaire (Knee Injury and Osteoarthritis Outcome Score) on several timepoints. 1 year
See also
  Status Clinical Trial Phase
Completed NCT01206634 - Regenerative Injection Therapy and Osteoarthritis Phase 4
Not yet recruiting NCT04001699 - Interprofessional Preoperative Geriatric Assessment for Older Arthroplasty Patients With Multimorbidity N/A